Quantcast

Latest Simvastatin Stories

2014-08-15 23:07:08

Simvastatin Could Boost Effectiveness of Chemotherapy Drug Pemetrexed DALLAS (PRWEB) August 15, 2014 A team of Korean researchers has found that a drug normally used to lower cholesterol could also help a commonly used chemotherapy medication kill malignant mesothelioma cells, the mesothelioma law firm of Baron and Budd reports. The results of the research team’s work was published in the latest issue of the International Journal of Oncology....

2014-06-30 23:19:55

On June 24, the FDA announced that 7,379 bottles (lot 3121005) of Red Yeast Rice dietary supplement, by Doctor's Best, are recalled because they were found to contain undeclared Lovastatin. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 30, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on...

2014-06-06 23:05:52

Patients with a particularly stubborn type of breast cancer could potentially benefit by supplementing radiation treatments with a generic, low-cost medication commonly prescribed to treat high cholesterol, according to a new study released today in Stem Cells Translational Medicine. Durham, NC (PRWEB) June 06, 2014 Patients with a particularly stubborn type of breast cancer could potentially benefit by supplementing radiation treatments with a generic, low-cost medication commonly...

2014-06-03 23:01:37

The Firm is evaluating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the statin medication. New York, New York (PRWEB) June 03, 2014 As Lipitor lawsuit claims (http://www.thelipitorlawsuit.com/) involving allegations that the popular statin drug causes Type 2 diabetes continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that a newly-released study has found that high-potency doses of Lipitor and other statins may...

2014-05-13 16:26:32

THOUSAND OAKS, Calif., May 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the publication of data from the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) study in the Journal of the American Medical Association (JAMA). Results from the 12-week study, which evaluated 1,896 patients with high cholesterol, showed treatment with subcutaneous evolocumab (140 mg every two weeks or 420 mg monthly) in combination with...

2014-03-30 08:20:05

Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday THOUSAND OAKS, Calif., March 30, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new detailed data from two Phase 3 pivotal studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant...

2014-03-25 23:02:29

Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina. (PRWEB) March 25, 2014 The law firm McSweeney / Langevin continues to advise women regarding potential legal claims regarding a possible link between use of Lipitor and the development of type 2 diabetes. Recently, federal litigation involving Pfizer, and plaintiffs alleging Lipitor caused type 2 diabetes, was centralized in South Carolina following...

Multiple Sclerosis May Benefit From Statins
2014-03-19 10:09:06

Brett Smith for redOrbit.com - Your Universe Online At first, multiple sclerosis is recognized by sporadic neurological symptoms – a condition called relapsing-remitting MS. Within a decade or so, greater than 50 percent of patients acquire secondary progressive MS, a continuous deterioration of symptoms and boost in disability. Currently, there are no approved drugs for treating this later stage of the disease. However, a newly published study in the UK medical journal The Lancet has...

2014-03-11 08:29:53

Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 /PRNewswire/ -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced that it has secured $45 million in Series B financing. New Enterprise Associates (NEA) led the financing,...

2014-02-19 23:27:12

AlignLife provides a free webinar to educate on Cholesterol and the risk of statin medications. (PRWEB) February 19, 2014 This Thursday, February 20th at 7pm EST, AlignLife clinics will be hosting a free webinar to educate the community about the dangers of statin medications and a natural approach to the management of cholesterol. An interesting study published in The Lancet looked at the incidence of heart disease in 52 countries and revealed that over 90% of heart disease is...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related